Evidence map›Paper›PMID 35592420›Full record

ArticleFrontiers in pharmacology2022

Exploration on Varying Patterns of Morphological Features and Quality of Armeniacae Semen Amarum in Rancid Process Based on Colorimeter, Electronic Nose, and GC/MS Coupled With Human Panel.

Yuanyang Shao, Huirong Chen, Hongxin Lin, Huishang Feng, Jianting Gong, Guangzhao Cao, Weifeng Hong, Yuebao Yao, Huiqin Zou, Yonghong Yan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Antioxidant Activity and Preclinical Safety ofInternational journal of molecular sciences · 2024
    Article
  3. Frontiers in pharmacology · 2024
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yuanyang ShaoSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Huirong ChenClinical Study Department, Beijing Highthink Pharmaceutical Technology Service Co., Ltd., Beijing, China.
Hongxin LinSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Huishang FengDepartment of Dermatology, Dongzhimen Hospital Beijing University of Chinese Medicine, Beijing, China.
Jianting GongChinese Medicine Resource Research Center, Beijing Institute of Clinical Pharmacy, Beijing, China.
Guangzhao CaoSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Weifeng HongSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Yuebao YaoSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Huiqin ZouSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Yonghong YanSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Beijing University of Chinese Medicine · CNDongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · CNFirst Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, the domestic and international trade volumes of Chinese medicinal materials (CMMs) keep increasing. By the end of 2019, the total amount of exported CMMs reached as high as US $1.137 billion, while imported was US $2.155 billion. A stable and controllable quality system of CMMs apparently becomes the most important issue, which needs multifaceted collaboration from harvesting CMMs at a proper season to storing CMMs at a proper temperature. However, due to imperfect storage conditions, different kinds of deteriorations are prone to occur, for instance, get moldy or rancid, which not only causes a huge waste of CMM resources but also poses a great threat to clinical medication safety and public health. The key issue is to quickly and accurately distinguish deteriorated CMM samples so as to avoid consuming low-quality or even harmful CMMs. However, some attention has been paid to study the changing quality of deteriorated CMMs and a suitable method for identifying them. In this study, as a medicine and food material which easily becomes rancid, armeniacae semen amarum (ASA) was chosen as a research objective, and experimental ASA samples of different rancidness degrees were collected. Then, various kinds of analytical methods and technologies were applied to explore the changing rules of ASA quality and figure out the key indicators for the quality evaluation of ASA in the rancid process, including the human panel, colorimeter, electronic nose, and GC/MS. This study aims to analyze the correlation between the external morphological features and the inner chemical compounds, to find out the specific components from "quantitative change" to "qualitative change" in the process of "getting rancid," and to discover the dynamic changes in the aforementioned key indicators at different stages of rancidness. The results showed since ASA samples began to get rancid with the extension of storage time, morphological features, namely, surface color and smell, changed significantly, and the degree of rancidness further deepened at the same time. Based on macroscopic identification accomplished

Indexed as

armeniacae semen amarumcolorimeterelectronic nosegas chromatography–mass spectrometryhuman panel

Identifiers

PMID35592420
PMCPMC9110824
OpenAlexW4225407915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.